Whitehall International INC

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$272Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
40clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $230
2020 $43K
2021 $138K
2022 $1,812
2023 $28K
2024 $44K
2025 $16K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Specialties it works with most

Rheumatology $69K
Gastroenterology (Internal Medicine) $36K
Hematology & Oncology $34K
Medical Oncology $18K
Infectious Disease $16K
Neurology (Psychiatry & Neurology) $14K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Vibeke Strand Portola Valley, CA Rheumatology $21,743.00
Marla Dubinsky New York, NY $19,572.00
Michael Weinblatt Boston, MA Rheumatology $18,500.00
Kevin Winthrop Portland, OR Infectious Disease $16,000.00
Shanu Modi New York, NY Medical Oncology $14,458.51
Bruce Sands New York, NY Gastroenterology (Internal Medicine) $14,146.23
Lawrence Eichenfield San Diego, CA Pediatric Dermatology $12,750.00
Stanley Cohen Dallas, TX Rheumatology $11,500.00
Michael Chiorean Issaquah, WA Gastroenterology (Internal Medicine) $11,375.00
Roy Fleischmann Dallas, TX $8,500.00

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.